By Sy Mukherjee
Genetic testing firm Color Genomics has been focused on cancer, the number two cause of death in America. But the upstart is now spreading its reach to the leading killer in the U.S.—heart disease.
Color announced Thursday that it’s introducing a Hereditary High Cholesterol Test that can detect a genetic mutation indicating Familial Hypercholesterolemia (FH), a genetic disorder which leaves carriers with high cholesterol that often leads to early heart disease. The test must be administered by a doctor and costs $249 for new customers.
FH can be a fairly common condition depending on whether or not you have inherited the mutation from one or both parents. The one-parent variety afflicts one in 250 people worldwide—in the U.S., an estimated 1.3 million people have FH, according to the FH Foundation.
Read more on Fortune.
Partner Spotlight: Q & A with The Belmont Data Collaborative
2022 Year in Review + Looking Ahead to 2023
Mark Yancy, NashvilleHealth CEO, on Building a Value Proposition for Health Equity
Partner Spotlight: Q & A with The Nashville Food Project
NashvilleHealth to Tackle Health Challenges Impacting Black Families
NashvilleHealth creates a culture of health and wellbeing by serving as a convener to open dialogue, align resources and build smart strategic partnerships to create a bold plan for health and wellbeing in Nashville.
Check out our latest newsletter© Copyright 2019 NashvilleHealth